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Cotinine antagonizes the behavioral effects of nicotine exposure 
in the planarian Girardia tigrina
Daniel J. Bach, Matthew Tenaglia, Debra L. Baker, Sean Deats, Erica Montgomery, and Oné 
R. Pagán*
Department of Biology, West Chester University, West Chester, PA
Abstract
Nicotine is one of the most addictive drugs abused by humans. Our laboratory and others have 
demonstrated that nicotine decreases motility and induces seizure-like behavior in planarians 
(pSLM, which are vigorous writhing and bending of the body) in a concentration-dependent 
manner. Nicotine also induces withdrawal-like behaviors in these worms. Cotinine is the major 
nicotine metabolite in humans, although it is not the final product of nicotine metabolism. Cotinine 
is mostly inactive in vertebrate nervous systems and is currently being explored as a molecule 
which possess most of nicotine’s beneficial effects and few of its undesirable ones. It is not known 
whether cotinine is a product of nicotine metabolism in planarians. We found that cotinine by itself 
does not seem to elicit any behavioral effects in planarians up to a concentration of 1 mM. We also 
show that cotinine antagonizes the aforementioned nicotine-induced motility decrease and also 
decreases the expression of nicotine-induced pSLMs in a concentration-dependent manner. Also 
cotinine prevents the manifestation of some of the withdrawal-like behaviors induced by nicotine 
in our experimental organism. Thus, we obtained evidence supporting that cotinine antagonizes 
nicotine in this planarian species. Possible explanations include competitive binding of both 
compounds at overlapping binding sites, at different nicotinic receptor subtypes, or maybe 
allosteric interactions.
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1. Introduction
Planarians are freshwater flatworms and are excellent model organisms in the field of 
neurobiology, regeneration and pharmacology research. Their multipolar neurons are more 
similar to vertebrates than to more evolved invertebrates, displaying a primitive bilateral 
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brain and featuring many of the neurotransmitters found in vertebrates [1,2]. Recent 
pharmacological research shows planarians being used as models for abused compounds 
such as cocaine, amphetamines, and nicotine among others [3-6].
Nicotine is one of the most commonly abused substances in the world that leads to addiction 
[7]. It is best-known as a component of tobacco products [8] and its main molecular target 
are nicotinic acetylcholine receptors [9]. In planarians, nicotine displays an increase in 
motility at lower concentrations, a decrease in motility at higher concentrations, and an 
increase in planarian seizure like movements (pSLM) [10,11]. Planarians exposed to 
nicotine for a period of about 24 hours display a series of withdrawal-like behaviors [5].
Cotinine is the major metabolite of nicotine in humans and both molecules are very similar 
structurally, the only difference being a carbonyl group. Despite this close structural 
similarity, cotinine does not display the same effects as nicotine [12]. For example, upon 
consumption of tobacco products, cotinine is found in the blood at higher levels than 
nicotine and is metabolized at a slower rate. Moreover, cotinine is not the final step in 
nicotine metabolism. In bovine adrenal chromafin cells, cotinine has shown to desensitize 
nicotinic responses and inhibit protein kinase C activation [13,14]). In rats, cotinine was 
found to have a binding affinity approximately three orders of magnitude lower than nicotine 
[15]. To the best of our knowledge, this is the first work describing nicotine-cotinine 
interactions in planarians. This work will contribute to the characterization of nicotinic 
cholinergic systems in our experimental organism.
2. Materials and methods
Brown planarians (Girardia tigrina) were purchased from Ward’s (Rochester, NY). Cotinine 
and nicotine were purchased from Tocris, (Bristol, UK). Other laboratory materials and 
supplies were purchased from Fisher scientific (Suwanee, GA) or Sigma-Aldrich (St. Louis, 
MO). The graphs/statistical analyses were done with the Prism software package (GraphPad 
Inc., San Diego, CA).
Planarians were transferred to artificial pond water (APW, NaCl, 6mM; NaHCO3, 0.1 mM; 
CaCl2, 0.6 mM) upon arrival, and were acclimated to these conditions for at least 24 hours 
before use. All planarians received were used within three weeks of arrival. The APW was 
changed at least once every day except during weekends and always before experiments. All 
petri dishes, ceramic wells, graduated cylinders and microcentrifuge tubes were rinsed with 
APW before experiments. All experiments were performed at room temperature in APW. 
All reagents were prepared as APW solutions.
Planarian motility and seizure like movements were studied using established laboratory 
protocols [11,16,17]. To determine the planarian motility, a planarian (1.0-1.5 cm long) was 
placed in a clear APW-rinsed 6 cm polystyrene petri dish and placed over a 1cm2 grid. 5mL 
of experimental solutions (APW, nicotine 10-1000 μM, cotinine 10- 1000 μM, and 
combination 10-1000 μM nicotine/1000 μM cotinine) were added and the cumulative 
crosses were counted over a period of 8 minutes [16]. For pSLM, measurements a planarian 
was placed in an APW rinsed ceramic well. The ceramic well was filled with experimental 
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solution (APW, nicotine 10-1000μM, cotinine 10-1000 μM, combination nicotine 1000 μM/
cotinine 100-1000 μM) and pSLMs were observed and counted over a period of 10 minutes. 
The use of these ceramic containers allowed us to minimize the amount of reagents used. 
Withdrawal-like behavior experiments were adapted from established protocols [5]. 
Planarians were placed individually in 1.5 mL microcentrifuge tubes with experimental 
solutions of either APW, 100 μM nicotine, 100 μM cotinine, or a combination of 100 μM 
nicotine/100 μM cotinine and were closed for 21-26 hours. After this time, planarians were 
transferred to a ceramic well with APW in the absence of any other compounds and 
measured for the following movements: ‘headbop’ (bobbing head while moving), 
‘corkscrew’ (spiral movement while in motion), ‘tailtwist’(twisting of the tail), ‘headswing’
(head movement while tail is anchored), and ‘squirming’(jerking or scrunching of the body) 
as described in [4]. Measurements occurred at three time periods, 0-5 minutes, 30-35 
minutes, and 60-65 minutes.
3. Results
When measuring motility of the planarians exposed to 10 μM-1000 μM nicotine, they 
experienced a concentration-dependent decrease in velocity (Figure 1), with an IC50 of 162 
μM. However, when exposed to the same amount of cotinine (10 μM-1000 μM), no 
significant motility decrease was observed. On the other hand, the presence of 1 mM 
cotinine significantly shifted the apparent nicotine IC50 to 490 μM, a threefold difference 
(Figure 1, p-value = 0.002, F-test).
When planarians were exposed to nicotine in solution with concentrations ranging from 10 
μM-2000 μM, they experienced a concentration-dependent increase in pSLMs (For an 
example of such a concentration-response curve please see [18]). Cotinine, however, at 
ranges from 10 μM-1000 μM, caused no changes in pSLM when compared with controls of 
APW (data not shown). However, when the worms were co-exposed to a single 
concentration of nicotine (1 mM) concurrently with various concentrations of cotinine (100 
μM - 1 mM), nicotine displayed a significant concentration-dependent cotinine-induced 
decrease in pSLMs (Figure 2).
Planarians exposed to nicotine for a period close to 24 hours expressed withdrawal-like 
behaviors, while those exposed to cotinine did not show any significant difference from 
control worms. However, when nicotine and cotinine were combined (Figure 3) although a 
qualitative decrease in the number of withdrawal-like behaviors were observed in some 
cases, these were not statistically significant as plotted. On the other hand, when the data 
was expressed, not as the number of events over time but rather, as the cumulative number of 
events in the presence of the compound combinations, we were able to observe a significant 
cotinine-induced decrease in some of the nicotine-induced withdrawal behaviors (Figure 4).
4. Discussion
Our experiments show several intriguing results in regards to nicotine/cotinine interaction in 
planarians. The first point is that these results confirm previous experiments in planarians 
using nicotine; namely, our results confirm that nicotine decreases motility, induces seizure-
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like movements, and still causes withdrawal-like behavioral effects after an approximately 
24 hour incubation [4,5,10,11]. Second, cotinine, a nicotine metabolite, elicits no 
statistically significant behavioral changes in our experimental organism, despite it being 
very structurally similar to nicotine.
The third and most important finding however, is that when these two compounds are in the 
same solution, the motility decrease and pSLM behaviors are significantly reduced when 
compared to the exposure of nicotine alone (Figures 1,2) which mimic acute exposure to 
nicotine. Cotinine also reduces the expression of three out of five nicotine-induced 
withdrawal-like behaviors that mimic chronic nicotine exposure (Figures 3,4).
Moreover, our work suggests that the molecular targets or maybe the mechanisms of 
nicotine that induce motility decrease, pSLMs and withdrawal-like behaviors may be 
independent of each other. Several points support this assertion. Cotinine does not 
antagonize all the nicotine-induced behaviors in all experiments (see Figures 3,4; 
withdrawal-like behaviors). In contrast, cotinine antagonizes both the motility decrease and 
the pSLMs induced by nicotine, albeit with different potencies. For example, in the motility 
studies, 1 mM cotinine is able to reduce the apparent nicotine potency threefold (Figure 1), 
while at the same concentration cotinine is only able to reduce nicotine’s potency to induce 
pSLMs by approximately 50 % (Figure 2).
We speculate that cotinine is binding to the same or overlapping binding site of nicotine or 
that cotinine is binding at an allosteric site changing the conformation of the receptor target. 
Moreover, it is known that there is a variety of nicotinic acetylcholine receptors described in 
vertebrates. Several of these have also been identified in certain planarian species [19,20]. It 
is quite possible that different types of nicotinic receptors may modulate different behavioral 
responses. Future experiments will include work using other cholinergic compounds to 
elucidate the various mechanisms through which nicotine induces its planarian-related 
behaviors.
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• Our experimental animal is the planarian.
• Cotinine antagonizes the nicotine-induced motility decrease.
• Cotinine antagonizes the nicotine-induced seizure-like movements.
• Cotinine antagonizes three types of nicotine-induced withdrawal 
behaviors.
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Concentration-response curve of the fraction of control of planarian motility vs. either 
nicotine alone, cotinine alone or the combination of both. Cotitine did not reduce planarian 
motility, while nicotine did, in agreement to previous work. Moreover, the presence of 
cotinine significantly shifted the apparent IC50 of nicotine threefoldwise to the right (162 
μM to 490 μM, p = 0.0002, see text). The symbols represent the average response of at least 
six worms. The data points were fit to the equation: Fraction of control = Bottom + (Top-
Bottom) / (1+10(log M Nicotine - LogIC50)). The error bars represent the standard error of the 
mean.
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Cotinine antagonizes the induction of pSMLs by nicotine in a concentration-dependent 
manner. The error bars represent the standard error of the mean. The bars are different from 
each other by ANOVA (P < 0.0001), and each bar represents the average of 4-16 worms. The 
individual p-values between bars shown above were calculated by the non-parametric Mann-
Whitney test.
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Cotinine fails to antagonize the induction of withdrawal-like behaviors induced by nicotine 
as a function of time, as indicated. The error bars represent the standard error of the mean. 
Each symbol represents the average of 4 to 8 worms. In all behaviors, the results (control, 
nicotine, cotinine, and nicotine/cotinine, as indicated) were not statistically significant from 
each other (Kuskal-Wallis test followed by a Dunns post-test). Whenever a symbol is not 
visible it means that it’s being overlapped by other symbols.
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Alternate analysis of the data in Figure 3. Cotinine antagonizes three out of the five nicotine- 
or cotinine-induced, withdrawal-like behaviors when analyzing them based on the 
cumulative number of events over the 65 minutes of each experiment. In none of the five 
cases cotinine induced the withdrawal-like behaviors, determined by comparing it to the 
control (APW; NS = Not Significant). Moreover, with the exception of the corkscrew and 
tail twist behaviors, the consistently observed pattern was: Cotinine vs Control = NS; 
Nicotine vs Control = Significant, Nicotine/Cotinine vs Control = back to NS. Thus, we 
interpret this data as the cotinine “alleviation” of the nicotine-induced withdrawal behaviors 
in three out of the five observed behaviors. P values were obtained by two-tailed, unpaired t-
tests. The error bars represent the standard error of the mean. Each bar represents the 
average of 4 to 8 worms.
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